AstraZeneca Settles Texas Medicaid Fraud Suits For $110M

Law360 (August 7, 2018, 8:41 PM EDT) -- Pharmaceutical giant AstraZeneca LP has agreed to pay $110 million to the state of Texas to settle lawsuits accusing the company of falsely marketing its drugs Seroquel and Crestor in violation of the Texas Medicaid Fraud Prevention Act, according to a Tuesday announcement by the state attorney general.

Texas Attorney General Ken Paxton said the company was accused of using misleading marketing schemes at a time when it was already under strict obligations of a 2010 federal “corporate integrity agreement” resulting from prior allegations of Medicaid fraud.

That federal agreement prohibited AstraZeneca from promoting off-label uses of its antipsychotic medication Seroquel...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!